Respuesto, Khirbie Clent D.
HRN: 22-64-59 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/26/2023
CEFUROXIME 750MG (VIAL)
02/26/2023
03/05/2023
IV
750mg
Q 12H
For Prophylaxis (Colles’ Fx, Right)
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bone & JointSkin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes